Spiolto® Respimat®

DRUG4 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Unknown Phase

Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy

CompletedNCT03003494

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2017-06-06End: 2018-07-30Updated: 2019-09-30

Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)

CompletedNCT03165045

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2017-05-26End: 2019-03-24Updated: 2020-04-09

A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler

CompletedNCT03663569

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2018-08-15End: 2019-10-04Updated: 2025-01-07

Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)

CompletedNCT03954132

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2019-06-07End: 2021-09-30Updated: 2024-04-24

Related Papers

EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS.

2023-05-312 citations

Effectiveness of chronic obstructive pulmonary disease (COPD) treatment with a combination of tiotropium / olodaterol in Polish standard clinical practice as measured by the improvement of the Clinical COPD Questionnaire score: an observational study.

2022-05-271 citations

Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL® non-interventional study

ERJ Open Research2021-07-012 citations

Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study.

2021-03-105 citations

A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study Protocol

International Journal of COPD2020-10-012 citations

Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in Italy

Pulmonary Therapy2020-06-184 citations

Late Breaking Abstract - Assessment of physical functioning and handling with Tiotropium/Olodaterol (T/O) in patients with COPD requiring long-acting dual bronchodilation in an Italian cohort of patients

2019-09-28